The impact of the pandemic on non-COVID-19 causes of death in the United States: a multiple cause of death analysis

IF 7.7 1区 医学 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH European Journal of Epidemiology Pub Date : 2025-03-19 DOI:10.1007/s10654-025-01214-z
Yu Li, Hang Li, Tim Adair
{"title":"The impact of the pandemic on non-COVID-19 causes of death in the United States: a multiple cause of death analysis","authors":"Yu Li, Hang Li, Tim Adair","doi":"10.1007/s10654-025-01214-z","DOIUrl":null,"url":null,"abstract":"<p>Multiple cause of death data allow for a more granular analysis of the pandemic’s impact on mortality from non-COVID-19 causes of death compared with analysis of a single underlying cause of each death because they are often a co-morbidity of COVID-19. This study estimates excess mortality in the US of non-COVID-19 causes measured as a multiple cause (reported anywhere on the death certificate). Death registration data were used to conduct Poisson regressions of 24 non-COVID-19 causes to estimate expected age-standardized death rates and excess mortality in 2020–21, including by place of death. The ratio of COVID-19 mortality (as underlying or contributing cause) to excess mortality of each non-COVID-19 cause was calculated. During 2020–21, 21 of 24 non-COVID-19 causes exhibited excess mortality, highest for pneumonia (males 126.5%; 95% confidence interval 116.6–136.9%), other respiratory diseases (males 45.2%; 42.2–48.2%), other kidney diseases (males 45.0%, 37.8–52.0%), diabetes (females 38.3%, 32.8–43.4%) and hypertensive heart disease (females 28.9%, 22.8–33.9%). Suicide and influenza mortality was lower than expected. The ratio of COVID-19 (underlying cause) to excess mortality was 74.2% (69.2–79.7%) for men and 68.7% (63.5–75.0%) for women, was significantly higher for hospital (over 90%) than home (less than 16%) deaths and varied greatly between causes. The pandemic led to excess mortality for almost all non-COVID-19 causes in the US when measured as a multiple cause, being particularly high in several non-communicable diseases that increase the risk of dying from COVID-19. COVID-19 appears underreported for home deaths due to its low ratio to excess mortality in this setting.</p>","PeriodicalId":11907,"journal":{"name":"European Journal of Epidemiology","volume":"183 1","pages":""},"PeriodicalIF":7.7000,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10654-025-01214-z","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Multiple cause of death data allow for a more granular analysis of the pandemic’s impact on mortality from non-COVID-19 causes of death compared with analysis of a single underlying cause of each death because they are often a co-morbidity of COVID-19. This study estimates excess mortality in the US of non-COVID-19 causes measured as a multiple cause (reported anywhere on the death certificate). Death registration data were used to conduct Poisson regressions of 24 non-COVID-19 causes to estimate expected age-standardized death rates and excess mortality in 2020–21, including by place of death. The ratio of COVID-19 mortality (as underlying or contributing cause) to excess mortality of each non-COVID-19 cause was calculated. During 2020–21, 21 of 24 non-COVID-19 causes exhibited excess mortality, highest for pneumonia (males 126.5%; 95% confidence interval 116.6–136.9%), other respiratory diseases (males 45.2%; 42.2–48.2%), other kidney diseases (males 45.0%, 37.8–52.0%), diabetes (females 38.3%, 32.8–43.4%) and hypertensive heart disease (females 28.9%, 22.8–33.9%). Suicide and influenza mortality was lower than expected. The ratio of COVID-19 (underlying cause) to excess mortality was 74.2% (69.2–79.7%) for men and 68.7% (63.5–75.0%) for women, was significantly higher for hospital (over 90%) than home (less than 16%) deaths and varied greatly between causes. The pandemic led to excess mortality for almost all non-COVID-19 causes in the US when measured as a multiple cause, being particularly high in several non-communicable diseases that increase the risk of dying from COVID-19. COVID-19 appears underreported for home deaths due to its low ratio to excess mortality in this setting.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
求助全文
约1分钟内获得全文 去求助
来源期刊
European Journal of Epidemiology
European Journal of Epidemiology 医学-公共卫生、环境卫生与职业卫生
CiteScore
21.40
自引率
1.50%
发文量
109
审稿时长
6-12 weeks
期刊介绍: The European Journal of Epidemiology, established in 1985, is a peer-reviewed publication that provides a platform for discussions on epidemiology in its broadest sense. It covers various aspects of epidemiologic research and statistical methods. The journal facilitates communication between researchers, educators, and practitioners in epidemiology, including those in clinical and community medicine. Contributions from diverse fields such as public health, preventive medicine, clinical medicine, health economics, and computational biology and data science, in relation to health and disease, are encouraged. While accepting submissions from all over the world, the journal particularly emphasizes European topics relevant to epidemiology. The published articles consist of empirical research findings, developments in methodology, and opinion pieces.
期刊最新文献
The impact of the pandemic on non-COVID-19 causes of death in the United States: a multiple cause of death analysis Effects of childhood and adult height on later life cardiovascular disease risk estimated through Mendelian randomization Identification of effect modifiers using a stratified Mendelian randomization algorithmic framework Epidemiology of first-time major lower extremity amputations– A Danish Nationwide cohort study from 2010 to 2021 Two-step pragmatic subgroup discovery for heterogeneous treatment effects analyses: perspectives toward enhanced interpretability
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1